Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Molecular therapy oncolytics

Showing results (1-10 of 813) with videos related to

Pageof 82
Sort By:
Molecular Therapy Oncolytics|November 25, 2021
hnRNPK-derived cell-penetratingpeptide inhibits cancer cell survivalPavan Kumar Puvvula, Stephanie Buczkowski, Anne M Moon
Molecular Therapy Oncolytics|November 25, 2021
Erratum: A New Tool for CRISPR-Cas13a-BasedCancer Gene TherapyJinliang Gao, Tao Luo, Na Lin, et al.
Molecular Therapy Oncolytics|November 11, 2021
A systematic analysis on the clinical safety and efficacy of onco-virotherapyDarshak K Bhatt, Lieske Wekema, Luciana Rodrigues Carvalho Barros, et al.
Molecular Therapy Oncolytics|March 19, 2021
PTOV1 promotes cisplatin-induced chemotherapy resistance by activating the nuclear factor kappa B pathway in ovarian cancerHongwei Shen, Bing Liao, Zhiyong Wan, et al.
Molecular Therapy Oncolytics|November 17, 2021
Cholesterol-enriched membrane micro-domaindeficiency induces doxorubicin resistancevia promoting autophagy in breast cancerYin Shi, Zu Ye, Guang Lu, et al.
Molecular Therapy Oncolytics|December 2, 2021
Sperm protein 17 targeting for epithelialovarian cancer treatment in the eraof modern immunoengineeringMaria Poplawska, Dibyendu Dutta, Yichun Lee, et al.
Molecular Therapy Oncolytics|March 9, 2019
Skp2 Expression Is Inhibited by Arsenic Trioxide through the Upregulation of miRNA-330-5p in Pancreatic Cancer CellsJiankun Gao, Gu Wang, Jingrong Wu, et al.
Molecular Therapy Oncolytics|January 3, 2022
NEBL and AKT1 maybe new targets to eliminate the colorectal cancer cells resistance to oncolytic effect of vesicular stomatitis virus M-proteinZoleikha Mamizadeh, Mohamad Reza Kalani, Masoud Parsania, et al.
Molecular Therapy Oncolytics|January 3, 2022
Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memoryRūta Veinalde, Gemma Pidelaserra-Martí, Coline Moulin, et al.
Molecular Therapy Oncolytics|January 13, 2022
Isolation of TCR genes with tumor-killing activity from tumor-infiltrating and circulating lymphocytes in a tumor rejection cynomolgus macaque modelKoji Terada, Kenta Kondo, Hirohito Ishigaki, et al.
Pageof 82

Showing results (1-10 of 813) with videos related to

Sort By:
Pageof 82
Molecular Therapy Oncolytics|November 25, 2021
hnRNPK-derived cell-penetratingpeptide inhibits cancer cell survivalPavan Kumar Puvvula, Stephanie Buczkowski, Anne M Moon
Molecular Therapy Oncolytics|November 25, 2021
Erratum: A New Tool for CRISPR-Cas13a-BasedCancer Gene TherapyJinliang Gao, Tao Luo, Na Lin, et al.
Molecular Therapy Oncolytics|November 11, 2021
A systematic analysis on the clinical safety and efficacy of onco-virotherapyDarshak K Bhatt, Lieske Wekema, Luciana Rodrigues Carvalho Barros, et al.
Molecular Therapy Oncolytics|March 19, 2021
PTOV1 promotes cisplatin-induced chemotherapy resistance by activating the nuclear factor kappa B pathway in ovarian cancerHongwei Shen, Bing Liao, Zhiyong Wan, et al.
Molecular Therapy Oncolytics|November 17, 2021
Cholesterol-enriched membrane micro-domaindeficiency induces doxorubicin resistancevia promoting autophagy in breast cancerYin Shi, Zu Ye, Guang Lu, et al.
Molecular Therapy Oncolytics|December 2, 2021
Sperm protein 17 targeting for epithelialovarian cancer treatment in the eraof modern immunoengineeringMaria Poplawska, Dibyendu Dutta, Yichun Lee, et al.
Molecular Therapy Oncolytics|March 9, 2019
Skp2 Expression Is Inhibited by Arsenic Trioxide through the Upregulation of miRNA-330-5p in Pancreatic Cancer CellsJiankun Gao, Gu Wang, Jingrong Wu, et al.
Molecular Therapy Oncolytics|January 3, 2022
NEBL and AKT1 maybe new targets to eliminate the colorectal cancer cells resistance to oncolytic effect of vesicular stomatitis virus M-proteinZoleikha Mamizadeh, Mohamad Reza Kalani, Masoud Parsania, et al.
Molecular Therapy Oncolytics|January 3, 2022
Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memoryRūta Veinalde, Gemma Pidelaserra-Martí, Coline Moulin, et al.
Molecular Therapy Oncolytics|January 13, 2022
Isolation of TCR genes with tumor-killing activity from tumor-infiltrating and circulating lymphocytes in a tumor rejection cynomolgus macaque modelKoji Terada, Kenta Kondo, Hirohito Ishigaki, et al.
Pageof 82